Innospec Inc. (NASDAQ:IOSP) Stock Position Lowered by Strs Ohio

Strs Ohio lessened its position in Innospec Inc. (NASDAQ:IOSPFree Report) by 4.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,500 shares of the specialty chemicals company’s stock after selling 400 shares during the period. Strs Ohio’s holdings in Innospec were worth $1,170,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of IOSP. SG Americas Securities LLC bought a new stake in shares of Innospec in the 3rd quarter worth $2,021,000. GSA Capital Partners LLP acquired a new stake in shares of Innospec during the third quarter worth $1,978,000. Bahl & Gaynor Inc. raised its position in shares of Innospec by 112.1% during the third quarter. Bahl & Gaynor Inc. now owns 34,824 shares of the specialty chemicals company’s stock worth $3,559,000 after purchasing an additional 18,407 shares during the period. Acadian Asset Management LLC raised its position in shares of Innospec by 19.7% during the third quarter. Acadian Asset Management LLC now owns 111,652 shares of the specialty chemicals company’s stock worth $11,393,000 after purchasing an additional 18,371 shares during the period. Finally, Illinois Municipal Retirement Fund acquired a new stake in shares of Innospec during the third quarter worth $1,490,000. Institutional investors own 96.64% of the company’s stock.

Insider Transactions at Innospec

In other news, VP Philip John Boon sold 3,715 shares of the company’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total transaction of $453,490.05. Following the completion of the sale, the vice president now owns 18,516 shares in the company, valued at approximately $2,260,248.12. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In related news, SVP David B. Jones sold 2,500 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $125.79, for a total transaction of $314,475.00. Following the completion of the transaction, the senior vice president now owns 9,664 shares of the company’s stock, valued at approximately $1,215,634.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Philip John Boon sold 3,715 shares of the business’s stock in a transaction dated Thursday, February 22nd. The stock was sold at an average price of $122.07, for a total value of $453,490.05. Following the transaction, the vice president now directly owns 18,516 shares of the company’s stock, valued at approximately $2,260,248.12. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,500 shares of company stock worth $4,532,959. 1.35% of the stock is owned by corporate insiders.

Innospec Stock Down 0.5 %

Shares of Innospec stock opened at $121.66 on Tuesday. The stock’s fifty day moving average is $124.31 and its 200-day moving average is $115.55. The firm has a market capitalization of $3.04 billion, a PE ratio of 21.84 and a beta of 1.10. Innospec Inc. has a 12-month low of $91.74 and a 12-month high of $131.18.

Innospec (NASDAQ:IOSPGet Free Report) last announced its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.59 by $0.25. Innospec had a return on equity of 13.69% and a net margin of 7.14%. The company had revenue of $494.70 million for the quarter, compared to analyst estimates of $479.47 million. During the same period in the previous year, the firm earned $1.20 earnings per share. Innospec’s revenue for the quarter was down 3.1% compared to the same quarter last year. Analysts expect that Innospec Inc. will post 6.77 EPS for the current year.

Innospec Profile

(Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Articles

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSPFree Report).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.